nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2E1—Dacarbazine—muscle cancer	0.206	0.345	CbGbCtD
Zopiclone—PTGS1—Etoposide—muscle cancer	0.13	0.218	CbGbCtD
Zopiclone—CYP2E1—Etoposide—muscle cancer	0.101	0.169	CbGbCtD
Zopiclone—CYP2C8—Etoposide—muscle cancer	0.0752	0.126	CbGbCtD
Zopiclone—CYP3A4—Vincristine—muscle cancer	0.0333	0.0558	CbGbCtD
Zopiclone—CYP3A4—Etoposide—muscle cancer	0.0305	0.0511	CbGbCtD
Zopiclone—CYP3A4—Doxorubicin—muscle cancer	0.0208	0.0349	CbGbCtD
Zopiclone—TSPO—hindlimb—muscle cancer	0.00815	0.129	CbGeAlD
Zopiclone—TSPO—appendage—muscle cancer	0.00699	0.111	CbGeAlD
Zopiclone—GABRG3—head—muscle cancer	0.00238	0.0378	CbGeAlD
Zopiclone—TSPO—embryo—muscle cancer	0.00232	0.0368	CbGeAlD
Zopiclone—GABRG3—testis—muscle cancer	0.0023	0.0365	CbGeAlD
Zopiclone—GABRA5—head—muscle cancer	0.00183	0.029	CbGeAlD
Zopiclone—TSPO—smooth muscle tissue—muscle cancer	0.00182	0.0289	CbGeAlD
Zopiclone—GABRA5—testis—muscle cancer	0.00177	0.0281	CbGeAlD
Zopiclone—TSPO—renal system—muscle cancer	0.00176	0.0279	CbGeAlD
Zopiclone—GABRA3—head—muscle cancer	0.0017	0.027	CbGeAlD
Zopiclone—GABRA3—testis—muscle cancer	0.00165	0.0261	CbGeAlD
Zopiclone—TSPO—cardiac atrium—muscle cancer	0.00157	0.0249	CbGeAlD
Zopiclone—GABRG2—head—muscle cancer	0.00139	0.022	CbGeAlD
Zopiclone—GABRB2—head—muscle cancer	0.00139	0.022	CbGeAlD
Zopiclone—GABRA2—vagina—muscle cancer	0.00137	0.0218	CbGeAlD
Zopiclone—TSPO—tendon—muscle cancer	0.00137	0.0217	CbGeAlD
Zopiclone—GABRB2—testis—muscle cancer	0.00134	0.0213	CbGeAlD
Zopiclone—TSPO—bone marrow—muscle cancer	0.00133	0.0211	CbGeAlD
Zopiclone—TSPO—vagina—muscle cancer	0.00127	0.0202	CbGeAlD
Zopiclone—GABRA2—head—muscle cancer	0.00127	0.0201	CbGeAlD
Zopiclone—GABRA1—head—muscle cancer	0.00123	0.0195	CbGeAlD
Zopiclone—CYP2C8—renal system—muscle cancer	0.00121	0.0191	CbGeAlD
Zopiclone—TSPO—head—muscle cancer	0.00118	0.0186	CbGeAlD
Zopiclone—TSPO—testis—muscle cancer	0.00114	0.018	CbGeAlD
Zopiclone—GABRB3—head—muscle cancer	0.00107	0.0169	CbGeAlD
Zopiclone—GABRB3—testis—muscle cancer	0.00103	0.0163	CbGeAlD
Zopiclone—PTGS1—smooth muscle tissue—muscle cancer	0.00102	0.0161	CbGeAlD
Zopiclone—CYP2E1—renal system—muscle cancer	0.00101	0.0161	CbGeAlD
Zopiclone—PTGS1—renal system—muscle cancer	0.000977	0.0155	CbGeAlD
Zopiclone—PTGS1—cardiac atrium—muscle cancer	0.000875	0.0139	CbGeAlD
Zopiclone—CYP2C8—vagina—muscle cancer	0.000873	0.0138	CbGeAlD
Zopiclone—Dry eye—Doxorubicin—muscle cancer	0.000869	0.00255	CcSEcCtD
Zopiclone—Cramps of lower extremities—Doxorubicin—muscle cancer	0.000864	0.00254	CcSEcCtD
Zopiclone—Erythema multiforme—Etoposide—muscle cancer	0.000861	0.00253	CcSEcCtD
Zopiclone—Rash maculo-papular—Doxorubicin—muscle cancer	0.000855	0.00251	CcSEcCtD
Zopiclone—Anorexia—Dactinomycin—muscle cancer	0.000852	0.0025	CcSEcCtD
Zopiclone—Bladder pain—Doxorubicin—muscle cancer	0.00085	0.0025	CcSEcCtD
Zopiclone—Mouth ulceration—Doxorubicin—muscle cancer	0.00085	0.0025	CcSEcCtD
Zopiclone—Convulsion—Vincristine—muscle cancer	0.000848	0.00249	CcSEcCtD
Zopiclone—Hypertension—Vincristine—muscle cancer	0.000845	0.00248	CcSEcCtD
Zopiclone—Myalgia—Vincristine—muscle cancer	0.000833	0.00245	CcSEcCtD
Zopiclone—Hypertonia—Doxorubicin—muscle cancer	0.000824	0.00242	CcSEcCtD
Zopiclone—Chills—Etoposide—muscle cancer	0.000817	0.0024	CcSEcCtD
Zopiclone—CYP3A4—renal system—muscle cancer	0.000816	0.0129	CbGeAlD
Zopiclone—Mental disability—Doxorubicin—muscle cancer	0.000816	0.0024	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000814	0.00239	CcSEcCtD
Zopiclone—Alopecia—Etoposide—muscle cancer	0.000805	0.00236	CcSEcCtD
Zopiclone—Lymphadenopathy—Doxorubicin—muscle cancer	0.0008	0.00235	CcSEcCtD
Zopiclone—Anaphylactic shock—Vincristine—muscle cancer	0.000799	0.00235	CcSEcCtD
Zopiclone—Infection—Vincristine—muscle cancer	0.000793	0.00233	CcSEcCtD
Zopiclone—CYP2E1—tendon—muscle cancer	0.000792	0.0126	CbGeAlD
Zopiclone—Thrombophlebitis—Doxorubicin—muscle cancer	0.000789	0.00232	CcSEcCtD
Zopiclone—Osteoarthritis—Methotrexate—muscle cancer	0.000788	0.00232	CcSEcCtD
Zopiclone—CYP2C8—testis—muscle cancer	0.000779	0.0124	CbGeAlD
Zopiclone—Photosensitivity—Doxorubicin—muscle cancer	0.000777	0.00228	CcSEcCtD
Zopiclone—Decreased appetite—Dactinomycin—muscle cancer	0.000777	0.00228	CcSEcCtD
Zopiclone—Dysgeusia—Etoposide—muscle cancer	0.000776	0.00228	CcSEcCtD
Zopiclone—Hyperhidrosis—Vincristine—muscle cancer	0.000772	0.00227	CcSEcCtD
Zopiclone—Fatigue—Dactinomycin—muscle cancer	0.000771	0.00226	CcSEcCtD
Zopiclone—Back pain—Etoposide—muscle cancer	0.000767	0.00225	CcSEcCtD
Zopiclone—Pain—Dactinomycin—muscle cancer	0.000764	0.00225	CcSEcCtD
Zopiclone—PTGS1—tendon—muscle cancer	0.000763	0.0121	CbGeAlD
Zopiclone—Muscle spasms—Etoposide—muscle cancer	0.000762	0.00224	CcSEcCtD
Zopiclone—Anorexia—Vincristine—muscle cancer	0.000761	0.00224	CcSEcCtD
Zopiclone—Eczema—Doxorubicin—muscle cancer	0.00076	0.00223	CcSEcCtD
Zopiclone—Irritability—Methotrexate—muscle cancer	0.000752	0.00221	CcSEcCtD
Zopiclone—Mood swings—Methotrexate—muscle cancer	0.000747	0.00219	CcSEcCtD
Zopiclone—Ataxia—Methotrexate—muscle cancer	0.000741	0.00218	CcSEcCtD
Zopiclone—Feeling abnormal—Dactinomycin—muscle cancer	0.000737	0.00216	CcSEcCtD
Zopiclone—Ill-defined disorder—Etoposide—muscle cancer	0.000735	0.00216	CcSEcCtD
Zopiclone—Anaemia—Etoposide—muscle cancer	0.000733	0.00215	CcSEcCtD
Zopiclone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000731	0.00215	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000728	0.00214	CcSEcCtD
Zopiclone—Increased appetite—Doxorubicin—muscle cancer	0.000727	0.00213	CcSEcCtD
Zopiclone—Insomnia—Vincristine—muscle cancer	0.000722	0.00212	CcSEcCtD
Zopiclone—Paraesthesia—Vincristine—muscle cancer	0.000717	0.00211	CcSEcCtD
Zopiclone—Malaise—Etoposide—muscle cancer	0.000715	0.0021	CcSEcCtD
Zopiclone—Dermatitis bullous—Doxorubicin—muscle cancer	0.000714	0.0021	CcSEcCtD
Zopiclone—Vertigo—Etoposide—muscle cancer	0.000712	0.00209	CcSEcCtD
Zopiclone—PTGS1—vagina—muscle cancer	0.000708	0.0112	CbGeAlD
Zopiclone—Abdominal pain—Dactinomycin—muscle cancer	0.000707	0.00208	CcSEcCtD
Zopiclone—Body temperature increased—Dactinomycin—muscle cancer	0.000707	0.00208	CcSEcCtD
Zopiclone—Decreased appetite—Vincristine—muscle cancer	0.000694	0.00204	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Vincristine—muscle cancer	0.000689	0.00203	CcSEcCtD
Zopiclone—Fatigue—Vincristine—muscle cancer	0.000688	0.00202	CcSEcCtD
Zopiclone—Convulsion—Etoposide—muscle cancer	0.000687	0.00202	CcSEcCtD
Zopiclone—Hypertension—Etoposide—muscle cancer	0.000684	0.00201	CcSEcCtD
Zopiclone—Pain—Vincristine—muscle cancer	0.000683	0.00201	CcSEcCtD
Zopiclone—Constipation—Vincristine—muscle cancer	0.000683	0.00201	CcSEcCtD
Zopiclone—Diplopia—Doxorubicin—muscle cancer	0.000683	0.00201	CcSEcCtD
Zopiclone—Osteoarthritis—Doxorubicin—muscle cancer	0.000683	0.00201	CcSEcCtD
Zopiclone—Asthma—Methotrexate—muscle cancer	0.000681	0.002	CcSEcCtD
Zopiclone—CYP2E1—head—muscle cancer	0.000679	0.0108	CbGeAlD
Zopiclone—Chest pain—Etoposide—muscle cancer	0.000675	0.00198	CcSEcCtD
Zopiclone—Affect lability—Doxorubicin—muscle cancer	0.000672	0.00197	CcSEcCtD
Zopiclone—Migraine—Doxorubicin—muscle cancer	0.000672	0.00197	CcSEcCtD
Zopiclone—Discomfort—Etoposide—muscle cancer	0.000667	0.00196	CcSEcCtD
Zopiclone—Face oedema—Doxorubicin—muscle cancer	0.000659	0.00194	CcSEcCtD
Zopiclone—Hypersensitivity—Dactinomycin—muscle cancer	0.000659	0.00193	CcSEcCtD
Zopiclone—CYP2E1—testis—muscle cancer	0.000656	0.0104	CbGeAlD
Zopiclone—PTGS1—head—muscle cancer	0.000654	0.0104	CbGeAlD
Zopiclone—Gastrointestinal pain—Vincristine—muscle cancer	0.000653	0.00192	CcSEcCtD
Zopiclone—Confusional state—Etoposide—muscle cancer	0.000652	0.00192	CcSEcCtD
Zopiclone—Anaphylactic shock—Etoposide—muscle cancer	0.000647	0.0019	CcSEcCtD
Zopiclone—Mood swings—Doxorubicin—muscle cancer	0.000647	0.0019	CcSEcCtD
Zopiclone—Infection—Etoposide—muscle cancer	0.000643	0.00189	CcSEcCtD
Zopiclone—Ataxia—Doxorubicin—muscle cancer	0.000642	0.00189	CcSEcCtD
Zopiclone—Asthenia—Dactinomycin—muscle cancer	0.000641	0.00188	CcSEcCtD
Zopiclone—Dysuria—Methotrexate—muscle cancer	0.000637	0.00187	CcSEcCtD
Zopiclone—Dehydration—Doxorubicin—muscle cancer	0.000635	0.00187	CcSEcCtD
Zopiclone—PTGS1—testis—muscle cancer	0.000632	0.01	CbGeAlD
Zopiclone—Tachycardia—Etoposide—muscle cancer	0.000631	0.00186	CcSEcCtD
Zopiclone—Abdominal pain—Vincristine—muscle cancer	0.000631	0.00185	CcSEcCtD
Zopiclone—Body temperature increased—Vincristine—muscle cancer	0.000631	0.00185	CcSEcCtD
Zopiclone—Erectile dysfunction—Methotrexate—muscle cancer	0.000628	0.00184	CcSEcCtD
Zopiclone—Dry skin—Doxorubicin—muscle cancer	0.000626	0.00184	CcSEcCtD
Zopiclone—Hyperhidrosis—Etoposide—muscle cancer	0.000625	0.00184	CcSEcCtD
Zopiclone—Photosensitivity reaction—Methotrexate—muscle cancer	0.000622	0.00183	CcSEcCtD
Zopiclone—Hypokalaemia—Doxorubicin—muscle cancer	0.000621	0.00183	CcSEcCtD
Zopiclone—Anorexia—Etoposide—muscle cancer	0.000617	0.00181	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000615	0.00181	CcSEcCtD
Zopiclone—Diarrhoea—Dactinomycin—muscle cancer	0.000612	0.0018	CcSEcCtD
Zopiclone—Drowsiness—Methotrexate—muscle cancer	0.000608	0.00179	CcSEcCtD
Zopiclone—Depression—Methotrexate—muscle cancer	0.000606	0.00178	CcSEcCtD
Zopiclone—Gastritis—Doxorubicin—muscle cancer	0.000604	0.00178	CcSEcCtD
Zopiclone—Muscular weakness—Doxorubicin—muscle cancer	0.000602	0.00177	CcSEcCtD
Zopiclone—Stomatitis—Methotrexate—muscle cancer	0.000592	0.00174	CcSEcCtD
Zopiclone—Conjunctivitis—Methotrexate—muscle cancer	0.000591	0.00174	CcSEcCtD
Zopiclone—Influenza—Doxorubicin—muscle cancer	0.00059	0.00173	CcSEcCtD
Zopiclone—Asthma—Doxorubicin—muscle cancer	0.00059	0.00173	CcSEcCtD
Zopiclone—Dysphagia—Doxorubicin—muscle cancer	0.00059	0.00173	CcSEcCtD
Zopiclone—Hypersensitivity—Vincristine—muscle cancer	0.000588	0.00173	CcSEcCtD
Zopiclone—Sweating—Methotrexate—muscle cancer	0.000582	0.00171	CcSEcCtD
Zopiclone—Paraesthesia—Etoposide—muscle cancer	0.000581	0.00171	CcSEcCtD
Zopiclone—Haematuria—Methotrexate—muscle cancer	0.000579	0.0017	CcSEcCtD
Zopiclone—Dyspnoea—Etoposide—muscle cancer	0.000577	0.00169	CcSEcCtD
Zopiclone—Somnolence—Etoposide—muscle cancer	0.000575	0.00169	CcSEcCtD
Zopiclone—Epistaxis—Methotrexate—muscle cancer	0.000573	0.00168	CcSEcCtD
Zopiclone—Asthenia—Vincristine—muscle cancer	0.000573	0.00168	CcSEcCtD
Zopiclone—Vomiting—Dactinomycin—muscle cancer	0.000568	0.00167	CcSEcCtD
Zopiclone—Bronchitis—Doxorubicin—muscle cancer	0.000567	0.00167	CcSEcCtD
Zopiclone—Rash—Dactinomycin—muscle cancer	0.000564	0.00166	CcSEcCtD
Zopiclone—Decreased appetite—Etoposide—muscle cancer	0.000562	0.00165	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000558	0.00164	CcSEcCtD
Zopiclone—Fatigue—Etoposide—muscle cancer	0.000558	0.00164	CcSEcCtD
Zopiclone—Pain—Etoposide—muscle cancer	0.000553	0.00163	CcSEcCtD
Zopiclone—Constipation—Etoposide—muscle cancer	0.000553	0.00163	CcSEcCtD
Zopiclone—Dysuria—Doxorubicin—muscle cancer	0.000552	0.00162	CcSEcCtD
Zopiclone—Diarrhoea—Vincristine—muscle cancer	0.000546	0.00161	CcSEcCtD
Zopiclone—Hepatitis—Methotrexate—muscle cancer	0.000545	0.0016	CcSEcCtD
Zopiclone—Pollakiuria—Doxorubicin—muscle cancer	0.000545	0.0016	CcSEcCtD
Zopiclone—Pharyngitis—Methotrexate—muscle cancer	0.000541	0.00159	CcSEcCtD
Zopiclone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000539	0.00158	CcSEcCtD
Zopiclone—Weight increased—Doxorubicin—muscle cancer	0.000537	0.00158	CcSEcCtD
Zopiclone—Weight decreased—Doxorubicin—muscle cancer	0.000534	0.00157	CcSEcCtD
Zopiclone—Feeling abnormal—Etoposide—muscle cancer	0.000533	0.00157	CcSEcCtD
Zopiclone—Nausea—Dactinomycin—muscle cancer	0.000531	0.00156	CcSEcCtD
Zopiclone—Gastrointestinal pain—Etoposide—muscle cancer	0.000529	0.00155	CcSEcCtD
Zopiclone—Dizziness—Vincristine—muscle cancer	0.000528	0.00155	CcSEcCtD
Zopiclone—Drowsiness—Doxorubicin—muscle cancer	0.000526	0.00155	CcSEcCtD
Zopiclone—Erythema multiforme—Methotrexate—muscle cancer	0.000516	0.00152	CcSEcCtD
Zopiclone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000516	0.00152	CcSEcCtD
Zopiclone—Urticaria—Etoposide—muscle cancer	0.000514	0.00151	CcSEcCtD
Zopiclone—Stomatitis—Doxorubicin—muscle cancer	0.000513	0.00151	CcSEcCtD
Zopiclone—Abdominal pain—Etoposide—muscle cancer	0.000511	0.0015	CcSEcCtD
Zopiclone—Body temperature increased—Etoposide—muscle cancer	0.000511	0.0015	CcSEcCtD
Zopiclone—Urinary tract infection—Doxorubicin—muscle cancer	0.000511	0.0015	CcSEcCtD
Zopiclone—Conjunctivitis—Doxorubicin—muscle cancer	0.000511	0.0015	CcSEcCtD
Zopiclone—Tinnitus—Methotrexate—muscle cancer	0.000509	0.00149	CcSEcCtD
Zopiclone—Vomiting—Vincristine—muscle cancer	0.000508	0.00149	CcSEcCtD
Zopiclone—Sweating—Doxorubicin—muscle cancer	0.000504	0.00148	CcSEcCtD
Zopiclone—Rash—Vincristine—muscle cancer	0.000504	0.00148	CcSEcCtD
Zopiclone—Dermatitis—Vincristine—muscle cancer	0.000503	0.00148	CcSEcCtD
Zopiclone—Haematuria—Doxorubicin—muscle cancer	0.000502	0.00147	CcSEcCtD
Zopiclone—Headache—Vincristine—muscle cancer	0.0005	0.00147	CcSEcCtD
Zopiclone—Epistaxis—Doxorubicin—muscle cancer	0.000496	0.00146	CcSEcCtD
Zopiclone—Chills—Methotrexate—muscle cancer	0.000489	0.00144	CcSEcCtD
Zopiclone—Alopecia—Methotrexate—muscle cancer	0.000482	0.00142	CcSEcCtD
Zopiclone—Hypersensitivity—Etoposide—muscle cancer	0.000477	0.0014	CcSEcCtD
Zopiclone—Nausea—Vincristine—muscle cancer	0.000474	0.00139	CcSEcCtD
Zopiclone—Rhinitis—Doxorubicin—muscle cancer	0.000473	0.00139	CcSEcCtD
Zopiclone—Hepatitis—Doxorubicin—muscle cancer	0.000472	0.00139	CcSEcCtD
Zopiclone—Hypoaesthesia—Doxorubicin—muscle cancer	0.00047	0.00138	CcSEcCtD
Zopiclone—Pharyngitis—Doxorubicin—muscle cancer	0.000469	0.00138	CcSEcCtD
Zopiclone—Oedema peripheral—Doxorubicin—muscle cancer	0.000465	0.00137	CcSEcCtD
Zopiclone—Dysgeusia—Methotrexate—muscle cancer	0.000465	0.00137	CcSEcCtD
Zopiclone—Asthenia—Etoposide—muscle cancer	0.000464	0.00136	CcSEcCtD
Zopiclone—Back pain—Methotrexate—muscle cancer	0.000459	0.00135	CcSEcCtD
Zopiclone—Pruritus—Etoposide—muscle cancer	0.000458	0.00134	CcSEcCtD
Zopiclone—Vision blurred—Methotrexate—muscle cancer	0.000447	0.00131	CcSEcCtD
Zopiclone—Erythema multiforme—Doxorubicin—muscle cancer	0.000447	0.00131	CcSEcCtD
Zopiclone—Diarrhoea—Etoposide—muscle cancer	0.000443	0.0013	CcSEcCtD
Zopiclone—Ill-defined disorder—Methotrexate—muscle cancer	0.000441	0.00129	CcSEcCtD
Zopiclone—Tinnitus—Doxorubicin—muscle cancer	0.00044	0.00129	CcSEcCtD
Zopiclone—Anaemia—Methotrexate—muscle cancer	0.000439	0.00129	CcSEcCtD
Zopiclone—Malaise—Methotrexate—muscle cancer	0.000428	0.00126	CcSEcCtD
Zopiclone—Dizziness—Etoposide—muscle cancer	0.000428	0.00126	CcSEcCtD
Zopiclone—Vertigo—Methotrexate—muscle cancer	0.000427	0.00125	CcSEcCtD
Zopiclone—Chills—Doxorubicin—muscle cancer	0.000424	0.00125	CcSEcCtD
Zopiclone—Alopecia—Doxorubicin—muscle cancer	0.000417	0.00123	CcSEcCtD
Zopiclone—Convulsion—Methotrexate—muscle cancer	0.000411	0.00121	CcSEcCtD
Zopiclone—Vomiting—Etoposide—muscle cancer	0.000411	0.00121	CcSEcCtD
Zopiclone—Rash—Etoposide—muscle cancer	0.000408	0.0012	CcSEcCtD
Zopiclone—Dermatitis—Etoposide—muscle cancer	0.000407	0.0012	CcSEcCtD
Zopiclone—Headache—Etoposide—muscle cancer	0.000405	0.00119	CcSEcCtD
Zopiclone—Chest pain—Methotrexate—muscle cancer	0.000404	0.00119	CcSEcCtD
Zopiclone—Myalgia—Methotrexate—muscle cancer	0.000404	0.00119	CcSEcCtD
Zopiclone—Tension—Doxorubicin—muscle cancer	0.000403	0.00119	CcSEcCtD
Zopiclone—Dysgeusia—Doxorubicin—muscle cancer	0.000403	0.00118	CcSEcCtD
Zopiclone—Discomfort—Methotrexate—muscle cancer	0.000399	0.00117	CcSEcCtD
Zopiclone—Nervousness—Doxorubicin—muscle cancer	0.000399	0.00117	CcSEcCtD
Zopiclone—Back pain—Doxorubicin—muscle cancer	0.000398	0.00117	CcSEcCtD
Zopiclone—Muscle spasms—Doxorubicin—muscle cancer	0.000395	0.00116	CcSEcCtD
Zopiclone—Confusional state—Methotrexate—muscle cancer	0.000391	0.00115	CcSEcCtD
Zopiclone—Anaphylactic shock—Methotrexate—muscle cancer	0.000387	0.00114	CcSEcCtD
Zopiclone—Vision blurred—Doxorubicin—muscle cancer	0.000387	0.00114	CcSEcCtD
Zopiclone—Infection—Methotrexate—muscle cancer	0.000385	0.00113	CcSEcCtD
Zopiclone—Nausea—Etoposide—muscle cancer	0.000384	0.00113	CcSEcCtD
Zopiclone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000381	0.00112	CcSEcCtD
Zopiclone—Anaemia—Doxorubicin—muscle cancer	0.00038	0.00112	CcSEcCtD
Zopiclone—Agitation—Doxorubicin—muscle cancer	0.000378	0.00111	CcSEcCtD
Zopiclone—Hyperhidrosis—Methotrexate—muscle cancer	0.000375	0.0011	CcSEcCtD
Zopiclone—Malaise—Doxorubicin—muscle cancer	0.000371	0.00109	CcSEcCtD
Zopiclone—Vertigo—Doxorubicin—muscle cancer	0.000369	0.00109	CcSEcCtD
Zopiclone—Anorexia—Methotrexate—muscle cancer	0.000369	0.00109	CcSEcCtD
Zopiclone—Palpitations—Doxorubicin—muscle cancer	0.000363	0.00107	CcSEcCtD
Zopiclone—Convulsion—Doxorubicin—muscle cancer	0.000356	0.00105	CcSEcCtD
Zopiclone—Hypertension—Doxorubicin—muscle cancer	0.000355	0.00104	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000353	0.00104	CcSEcCtD
Zopiclone—Insomnia—Methotrexate—muscle cancer	0.00035	0.00103	CcSEcCtD
Zopiclone—Chest pain—Doxorubicin—muscle cancer	0.00035	0.00103	CcSEcCtD
Zopiclone—Myalgia—Doxorubicin—muscle cancer	0.00035	0.00103	CcSEcCtD
Zopiclone—Anxiety—Doxorubicin—muscle cancer	0.000349	0.00102	CcSEcCtD
Zopiclone—Paraesthesia—Methotrexate—muscle cancer	0.000348	0.00102	CcSEcCtD
Zopiclone—Discomfort—Doxorubicin—muscle cancer	0.000346	0.00102	CcSEcCtD
Zopiclone—Dyspnoea—Methotrexate—muscle cancer	0.000345	0.00102	CcSEcCtD
Zopiclone—Somnolence—Methotrexate—muscle cancer	0.000344	0.00101	CcSEcCtD
Zopiclone—Dry mouth—Doxorubicin—muscle cancer	0.000342	0.00101	CcSEcCtD
Zopiclone—Dyspepsia—Methotrexate—muscle cancer	0.000341	0.001	CcSEcCtD
Zopiclone—Confusional state—Doxorubicin—muscle cancer	0.000338	0.000994	CcSEcCtD
Zopiclone—Decreased appetite—Methotrexate—muscle cancer	0.000337	0.00099	CcSEcCtD
Zopiclone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000336	0.000986	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000335	0.000983	CcSEcCtD
Zopiclone—Fatigue—Methotrexate—muscle cancer	0.000334	0.000982	CcSEcCtD
Zopiclone—Infection—Doxorubicin—muscle cancer	0.000333	0.000979	CcSEcCtD
Zopiclone—Pain—Methotrexate—muscle cancer	0.000331	0.000974	CcSEcCtD
Zopiclone—Tachycardia—Doxorubicin—muscle cancer	0.000327	0.000962	CcSEcCtD
Zopiclone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000324	0.000953	CcSEcCtD
Zopiclone—Anorexia—Doxorubicin—muscle cancer	0.00032	0.00094	CcSEcCtD
Zopiclone—Feeling abnormal—Methotrexate—muscle cancer	0.000319	0.000938	CcSEcCtD
Zopiclone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000317	0.000931	CcSEcCtD
Zopiclone—Urticaria—Methotrexate—muscle cancer	0.000308	0.000904	CcSEcCtD
Zopiclone—Abdominal pain—Methotrexate—muscle cancer	0.000306	0.0009	CcSEcCtD
Zopiclone—Body temperature increased—Methotrexate—muscle cancer	0.000306	0.0009	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000306	0.000898	CcSEcCtD
Zopiclone—Insomnia—Doxorubicin—muscle cancer	0.000303	0.000892	CcSEcCtD
Zopiclone—Paraesthesia—Doxorubicin—muscle cancer	0.000301	0.000885	CcSEcCtD
Zopiclone—Dyspnoea—Doxorubicin—muscle cancer	0.000299	0.000879	CcSEcCtD
Zopiclone—Somnolence—Doxorubicin—muscle cancer	0.000298	0.000876	CcSEcCtD
Zopiclone—Dyspepsia—Doxorubicin—muscle cancer	0.000295	0.000868	CcSEcCtD
Zopiclone—Decreased appetite—Doxorubicin—muscle cancer	0.000292	0.000857	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00029	0.000851	CcSEcCtD
Zopiclone—Fatigue—Doxorubicin—muscle cancer	0.000289	0.00085	CcSEcCtD
Zopiclone—Pain—Doxorubicin—muscle cancer	0.000287	0.000843	CcSEcCtD
Zopiclone—Constipation—Doxorubicin—muscle cancer	0.000287	0.000843	CcSEcCtD
Zopiclone—Hypersensitivity—Methotrexate—muscle cancer	0.000285	0.000839	CcSEcCtD
Zopiclone—Asthenia—Methotrexate—muscle cancer	0.000278	0.000817	CcSEcCtD
Zopiclone—Feeling abnormal—Doxorubicin—muscle cancer	0.000276	0.000812	CcSEcCtD
Zopiclone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000274	0.000806	CcSEcCtD
Zopiclone—Pruritus—Methotrexate—muscle cancer	0.000274	0.000805	CcSEcCtD
Zopiclone—Urticaria—Doxorubicin—muscle cancer	0.000267	0.000783	CcSEcCtD
Zopiclone—Abdominal pain—Doxorubicin—muscle cancer	0.000265	0.000779	CcSEcCtD
Zopiclone—Body temperature increased—Doxorubicin—muscle cancer	0.000265	0.000779	CcSEcCtD
Zopiclone—Diarrhoea—Methotrexate—muscle cancer	0.000265	0.000779	CcSEcCtD
Zopiclone—Dizziness—Methotrexate—muscle cancer	0.000256	0.000753	CcSEcCtD
Zopiclone—Hypersensitivity—Doxorubicin—muscle cancer	0.000247	0.000726	CcSEcCtD
Zopiclone—Vomiting—Methotrexate—muscle cancer	0.000246	0.000724	CcSEcCtD
Zopiclone—Rash—Methotrexate—muscle cancer	0.000244	0.000718	CcSEcCtD
Zopiclone—Dermatitis—Methotrexate—muscle cancer	0.000244	0.000717	CcSEcCtD
Zopiclone—Headache—Methotrexate—muscle cancer	0.000243	0.000713	CcSEcCtD
Zopiclone—Asthenia—Doxorubicin—muscle cancer	0.000241	0.000707	CcSEcCtD
Zopiclone—Pruritus—Doxorubicin—muscle cancer	0.000237	0.000697	CcSEcCtD
Zopiclone—Nausea—Methotrexate—muscle cancer	0.00023	0.000676	CcSEcCtD
Zopiclone—Diarrhoea—Doxorubicin—muscle cancer	0.00023	0.000675	CcSEcCtD
Zopiclone—Dizziness—Doxorubicin—muscle cancer	0.000222	0.000652	CcSEcCtD
Zopiclone—Vomiting—Doxorubicin—muscle cancer	0.000213	0.000627	CcSEcCtD
Zopiclone—Rash—Doxorubicin—muscle cancer	0.000212	0.000622	CcSEcCtD
Zopiclone—Dermatitis—Doxorubicin—muscle cancer	0.000211	0.000621	CcSEcCtD
Zopiclone—Headache—Doxorubicin—muscle cancer	0.00021	0.000618	CcSEcCtD
Zopiclone—Nausea—Doxorubicin—muscle cancer	0.000199	0.000586	CcSEcCtD
